Cardio Diagnostics Hldgs Analyst Ratings
Cardio Diagnostics Hldgs Analyst Ratings
Benchmark Co. Sticks to Their Buy Rating for Cardio Diagnostics Holdings (CDIO)
Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $8 Price Target
Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs With Outperform Rating, Announces Price Target of $8
Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Cardio Diagnostics Holdings (CDIO)
Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $8 Price Target
No Data